Search filters

List of works by James G Christensen

A novel ALK secondary mutation and EGFR signaling cause resistance to ALK kinase inhibitors

scientific article

Acquired Resistance to Crizotinib from a Mutation in CD74 – ROS1

scientific article

Activity of crizotinib (PF02341066), a dual mesenchymal-epithelial transition (MET) and anaplastic lymphoma kinase (ALK) inhibitor, in a non-small cell lung cancer patient with de novo MET amplification

scientific article

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer

scientific article

Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor.

scientific article

Crizotinib in ROS1-rearranged non-small-cell lung cancer.

scientific article

Initial Clinical Sensitivity and Acquired Resistance to MET Inhibition in MET-Mutated Papillary Renal Cell Carcinoma ⬇️

scientific article published on April 22, 2013

MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib

scientific article published on 31 October 2011

The Neuroblastoma-Associated F1174L ALK Mutation Causes Resistance to an ALK Kinase Inhibitor in ALK-Translocated Cancers ⬇️

scientific article published on October 28, 2010

Paulina is supported by:

About Paulina

Help